Science Daily

Allergies: Advances in understanding eosinophils

Researchers provide a better understanding of the origin of eosinophils and eosinophilia, and the effects of treatments targeting them. Eosinophils are specialized cells of our immune system. They are ...
Healio

Safety profiles similar for benralizumab, mepolizumab in severe eosinophilic asthma

Please provide your email address to receive an email when new articles are posted on . Benralizumab induces depletion of eosinophils and mepolizumab reduces activation. The study followed patients ...
ascopubs.org

Peripheral eosinophilia as a potential biomarker of response and immune-related adverse events in patients with gastrointestinal tumors treated with immune checkpoint ...

Incidence of colorectal cancer in the republic of Ireland: Trends and challenges. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text ...
PharmiWeb

MHRA authorises Nucala (mepolizumab) in the UK for the treatment of uncontrolled COPD of an eosinophilic phenotype for patients on triple therapy*

The approval is based on two placebo-controlled phase 3 studies, which showed mepolizumab significantly reduced the annualised rate of moderate/severe exacerbations and time to first moderate/severe ...
Nature

Development and validation of prognostic models using novel inflammatory markers for drug reactions with eosinophilia and systemic symptoms: An international multicenter cohort ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...